Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan

被引：8

作者：

Tahara, Nobuhiro ^{[1
]}

Mizoguchi, Minori ^{[1
]}

Honda, Akihiro ^{[1
]}

Tahara, Atsuko ^{[1
]}

Nitta, Yoshikazu ^{[1
]}

Kodama, Norihiro ^{[1
]}

Koiwaya, Hiroshi ^{[1
]}

Aoyagi, Shigeaki ^{[2
]}

Imaizumi, Tsutomu ^{[1
]}

机构：

[1] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan

[2] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2012年 / 158卷 / 02期

关键词：

Pulmonary arterial hypertension; Atrial septal defect; Bosentan; SEPTAL-DEFECT CLOSURE; THERAPY; EPOPROSTENOL;

D O I：

10.1016/j.ijcard.2011.10.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E38 / E40

页数：3

共 50 条

[31] Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?
Clozel, M
ANNALS OF MEDICINE, 2003, 35 (08) : 605 - 613
[32] Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis
Murdaca, Giuseppe
Lantieri, Francesca
Puppo, Francesco
Bezante, Gian Paolo
Balbi, Manrico
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 : 85 - 89
[33] Long-term inhaled iloprost use in children with pulmonary arterial hypertension
Alehan, Dursun
Yildirim, Isil
Sahin, Murat
Ozkutlu, Suheyla
Ozer, Sema
Karagoz, Tevfik
CARDIOLOGY IN THE YOUNG, 2012, 22 (04) : 396 - 403
[34] Long-term subcutaneous treprostinil (Remodulin) therapy for severe pulmonary arterial hypertension
Skoro-Sajer, N.
Bonderman, D.
Harja, E.
Jakowitsch, J.
Maurer, G.
Kneussl, M.
Lang, I. M.
EUROPEAN HEART JOURNAL, 2005, 26 : 79 - 79
[35] Close look at the Potts shunt flow hemodynamics in a patient with severe pulmonary hypertension: 4D-flow MRI evaluation
Schaefer, Michal
Frank, Benjamin S.
Ivy, D. Dunbar
Wilson, Neil
Morgan, Gareth J.
Barker, Alex J.
Browne, Lorna P.
Mitchell, Max B.
Truong, Uyen
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (06) : 1800 - 1802
[36] Long-term results of transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension in pediatric patients
Shah, Jayal Hasmukhbhai
Bhalodiya, Dharmin Khimjibhai
Rawal, Abhishek Pravinchandra
Nikam, Tushar Sudhakarrao
INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2020, 10 (01) : 3 - 7
[37] Long-Term Results of Transcatheter Closure of Large Patent Ductus Arteriosus With Severe Pulmonary Arterial Hypertension in Pediatric Patients
Shah, Jayal
Bhalodiya, Dharmin
Joshi, Dinesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B164 - B164
[38] Prolonged long-term survival in adults with Eisenmenger syndrome compared to other forms of pulmonary arterial hypertension related with congenital systemic-to-pulmonary shunt
Oliver, J. M.
Caraballo, E. Diaz
De Vinuesa, P. Gallego Garcia
Gonzalez, A.
Cantador, J. Ruiz
Recalde, A. Sanchez
Aroca, A.
Sobrino, J. A.
EUROPEAN HEART JOURNAL, 2005, 26 : 309 - 310
[39] Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension
Hsu, Hsao-Hsun
Chen, Jin-Shing
Chen, Robert J.
Ko, Wen-Je
Kuo, Shuenn-Wen
Wu, En-Ting
Wu, Mei-Hwan
Wang, Jou-Kou
Lee, Yung-Chie
RESPIRATORY MEDICINE, 2007, 101 (07) : 1556 - 1562
[40] Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease
Diller, Gerhard-Paul
Dimopoulos, Konstantinos
Kaya, Mehmet G.
Harries, Carl
Uebing, Anselm
Li, Wei
Koltsida, Evdokia
Gibbs, J. Simon R.
Gatzoulis, Michael A.
HEART, 2007, 93 (08) : 974 - 976

← 1 2 3 4 5 →